Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer

Academic Article

Overview
Identity
Additional Document Info
View All

authors

publication date

2013

journal

British Journal of Cancer Journal

subject areas